Metalloproteinases and angiogenesis;Métalloprotéinases et angiogenèse

Pathologie Biologie

Volumn 51, Issue 3, 2003, Pages 161-166

  Gabison, E E ^a,b   Hoang Xuan, T ^b   Mauviel, A ^a   Menashi, S ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Angiogenesis; Endothelial cells; Metalloproteinases

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3;

ANGIOGENESIS; BASEMENT MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; ENZYME MECHANISM; EXTRACELLULAR MATRIX; PROTEIN FUNCTION; REVIEW;

EID: 0037701192     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(03)00018-X     Document Type: Review

References (46)

1. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999;103(9):1231-6.
2. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993;157(2):351-8.
3. Anand-Apte B, et al. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol 1996;74(6):853-62.
4. Oh J, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001;107(6):789-800.
5. Weaver VM. Membrane-associated MMP regulators: novel cell adhesion tumor suppressor proteins? Dev Cell 2002;2(1):6-7.
6. Li H, et al. AdTIMP-2 inhibits tumor growth, angiogenesis and metastasis and prolongs survival in mice. Hum Gene Ther 2001;12(5):515-26.
7. Belotti D, Paganoni P, Giavazzi R. MMP inhibitors: experimental and clinical studies. Int J Biol Markers 1999;14(4):232-8.
8. Schnaper HW, et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993;156(2):235-46.
9. Kato T, et al. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 2001;508(2):187-90.
10. Hiraoka N, et al. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998;95(3):365-77.
11. Seandel M, et al. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Blood 2001;97(8):2323-32.
12. Stricker TP, et al. Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J Biol Chem 2001:29 375-81.
13. Galvez BG, et al. Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J Biol Chem 2001;276(40):37 491-500.
14. Brooks PC, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996;85(5):683-93.
15. Puyraimond A, et al. MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp Cell Res 2001;262(1):28-36.
16. Jiang A, et al. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 2001;98(24):13 693-8.
17. Toth M, et al. Complex Pattern of Membrane Type I Matrix Metalloproteinase Shedding. Regulation By Autocatalytic Cell Surface Inactivation Of Active Enzyme. J Biol Chem 2002;277(29):26 340-50.
18. Brooks PC, et al. Disruption of angiogenesis by Pex, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998;92(3):391-400.
19. Maeshima Y, et al. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 2002;295(5552):140-3.
20. Maeshima Y, et al. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem 2001;276(18):15 240-8.
21. Claesson-Welsh L, et al. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 1998;95(10):5579-83.
22. Rehn M, et al. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 2001;98(3):1024-9.
23. Kim YM, et al. Endostatin blocks VEGF-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 2002.
24. Xu J, et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 2001;154(5):1069-79.
25. Kraling BM, et al. The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J Cell Sci 1999;112(Pt 10):1599-609.
26. Bergers G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2(10):737-44.
27. Rodriguez-Manzaneque JC, et al. Thrombospondin-1 I suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci USA 2001;98(22):12485-90.
28. Yu Q, Yu I, Stamenkovic. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000;14(2):163-76.
29. Maeda S, et al. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Calcif Tissue Int 2002;70(1):54-65.
30. Mu D, et al. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 2002;157(3):493-507.
31. Folkman J, et al. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol 1988;130(2):393-400.
32. Whitelock JM, et al. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases. J Biol Chem 1996;271(17):10079-86.
33. Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 1999;103(9):1237-41.
34. Kamphaus GD, et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. po. J Biol Chem 2000;275(2):1209-15.
35. Maeshima Y, et al. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J Biol Chem 2001;276(34):31 959-68.
36. Ergun S, et al. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis 2001;4(3):193-206.
37. Itoh T, et al. Reduced angiogenesis and tumor progression in gelati-nase A-deficient mice. Cancer Res 1998;58(5):1048-51.
38. O'Reilly MS, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79(2):315-28.
39. O'Reilly MS, et al. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem 1999;274(41):29 568-71.
40. O'Reilly MS, et al. Endostatin: an endogenous inhibitor of angiogen-esis and tumor growth. Cell 1997;88(2):277-85.
41. Lin HC, et al. Matrilysin cleavage of corneal collagen type XVIII NC 1 domain and generation of a 28-kDa fragment. Invest Ophthalmol Vis Sci 2001;42(11):2517-24.
42. Ferreras M, et al. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 2000;486(3):247-51.
43. Colorado PC, et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 2000;60(9):2520-6.
44. Vu TH, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998;93(3):411-22.
45. Hudlicka O, et al. Factors involved in capillary growth in the heart. Mol Cell Biochem 1995;147(1-2):57-68.
46. Pozzi A, et al. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 2000;97(5):2202-7.